Listed Company

Clinuvel Pharmaceuticals Limited (ASX CUV)


Followers 46
Exchange ASX
Sector Health Care
Industry Pharmaceuticals, Biotechnology & Life Sciences

Latest News on Clinuvel Pharmaceuticals Limited


Covering Clinuvel Pharmaceuticals Limited


James Gerrish
Market Matters
Rudi Filapek-Vandyck
FNArena
Marcus Padley
Marcus Today
Kingsley Jones
Jevons Global
Michael Frazis
Frazis Capital
Claire Aitchison
Independent Investment Research

Clinuvel Pharmaceuticals Limited (ASX:CUV) is an Australian publicly listed company that trades on the Australian Stock Exchange. The company's stock code is CUV. Livewire Markets has 9 experts who have published 9 articles that have featured Clinuvel Pharmaceuticals Limited. You can view all those wires here. The last time time CUV was featured was on the 01 September 2023 by Rudi Filapek-Vandyck in the wire “FNArena reporting season monitor: August 2023 – Week Five (372 stocks covered)”. Get the latest CUV share price and other key information like CUV Financials on Market Index.